Clopidogrel

  Cat. No.:  DCAPI1417  
Chemical Structure
113665-84-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Clopidogrel is an irreversible inhibitor of the P2Y12 receptor, which is responsible for initiating signal transduction via a GPCR. The signal cascade initiates platelet aggregation and thus clopidogrel has the effect of “thinning” the blood.
Cas No.: 113665-84-2
SMILES: O=C(OC)[C@H](C1=C(Cl)C=CC=C1)N2CC(C=CS3)=C3CC2.OS(O)(=O)=O
Formula: C16H16ClNO2S
M.Wt: 321.83
Purity: >99%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: For the detailed information of Clopidogrel, the solubility of Clopidogrel in water, the solubility of Clopidogrel in DMSO, the solubility of Clopidogrel in PBS buffer, the animal experiment(test) (test) of Clopidogrel, the cell expriment (test) of Clopidogrel, the in vivo, in vitro and clinical trial test of Clopidogrel, the EC50, IC50,and Affinity of Clopidogrel,, please contact DC Chemicals.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DCAPI1417 Clopidogrel Clopidogrel is an irreversible inhibitor of the P2Y12 receptor, which is responsible for initiating signal transduction via a GPCR. The signal cascade initiates platelet aggregation and thus clopidogrel has the effect of “thinning” the blood.
X